Massively Parallel Sequencing Technology in Pathogenic Microbes

Abstract

Next-Generation Sequencing (NGS) methods have revolutionized various aspects of genomics including transcriptome analysis. Digital expression analysis is all set to replace analog expression analysis that uses microarray chips through their cost-effectiveness, reproducibility, accuracy, and speed. The last 2 years have seen a surge in the development of statistical methods and software tools for analysis and visualization of NGS data. Large amounts of NGS data are available for pathogenic fungi and oomycetes. As the analysis results start pouring in, it brings about a paradigm shift in the understanding of host pathogen interactions with discovery of new transcripts, splice variants, mutations, regulatory elements, and epigenetic controls. Here we describe the core technology of the new sequencing platforms, the methodology of data analysis, and different aspects of applications.

An Update on Neonatal and Pediatric Conjunctivitis

“…DNA sequencing is one tool that may become more widespread in identifying and treating conjunctivitis [88][89][90]. Additionally, promising new therapeutic agents may soon be available in treatment of conjunctivitis.…”

Role of Molecular Diagnostics in Ocular Microbiology

“…PCR cannot identify unexpected organisms in the way that culture can. Deep DNA sequencing for pathogen detection allows detection of all foreign DNA within a sample, and may allow discovery of novel pathogens [97,98]. Techniques utilizing biome representative sequencing [99] in particular have the potential to rapidly and cheaply identify all known and unknown organism in a biopsy.…”